Amrutanjan Healt

55
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
656.95
-10.05 (-1.51%)
BSENSE

Dec 05

BSE+NSE Vol: 9.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Mar'11
No of Months
12
12
12
12
12
12
Operating Income
195.00
174.00
148.00
145.00
149.00
109.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
9.00
8.00
7.00
7.00
6.00
4.00
Net Sales
186.00
166.00
141.00
137.00
143.00
105.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
66.00
62.00
56.00
59.00
65.00
43.00
Power & Fuel Cost
1.00
1.00
1.00
1.00
1.00
1.00
Employee Cost
28.00
25.00
22.00
21.00
19.00
16.00
Operating Expenses
7.00
6.00
5.00
4.00
5.00
3.00
General and Administration Expenses
10.00
9.00
8.00
7.00
7.00
6.00
Selling and Distribution Expenses
39.00
35.00
24.00
23.00
24.00
20.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
1.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
155.00
142.00
120.00
120.00
124.00
92.00
Operating Profit (PBDIT) excl Other Income
30.00
23.00
20.00
17.00
18.00
13.00
Other Income
5.00
4.00
3.00
4.00
4.00
4.00
Operating Profit (PBDIT)
36.00
28.00
24.00
21.00
22.00
17.00
Interest
0.00
0.00
1.00
2.00
3.00
0.00
Profit before Depriciation and Tax
36.00
27.00
22.00
19.00
19.00
17.00
Depreciation
3.00
3.00
3.00
3.00
3.00
1.00
Profit Before Taxation & Exceptional Items
32.00
24.00
19.00
15.00
16.00
15.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
32.00
24.00
19.00
15.00
15.00
15.00
Provision for Tax
12.00
9.00
6.00
5.00
6.00
5.00
Profit After Tax
20.00
14.00
12.00
10.00
9.00
10.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
5.00
0.00
Profit Balance B/F
41.00
32.00
30.00
30.00
25.00
24.00
Profit Available for appropriations
61.00
47.00
43.00
41.00
41.00
34.00
Appropriations
61.00
47.00
43.00
41.00
41.00
34.00
Equity Dividend (%)
192.50%
175.00%
160.00%
150.00%
150.00%
150.00%
Earnings Per Share
14.08
10.20
8.51
6.92
32.47
33.70
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 12.33% vs 16.54% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 29.97% vs 12.71% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024

Compare Profit and Loss Results of Amrutanjan Healt
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
195.00
0
195.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
9.00
0
9.00
0%
Net Sales
186.00
0
186.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
66.00
0
66.00
0%
Power & Fuel Cost
1.00
0
1.00
0%
Employee Cost
28.00
0
28.00
0%
Operating Expenses
7.00
0
7.00
0%
General and Administration Expenses
10.00
0
10.00
0%
Selling and Distribution Expenses
39.00
0
39.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
1.00
0
1.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
155.00
0
155.00
0%
Operating Profit (PBDIT) excl Other Income
30.00
0.00
30.00
0%
Other Income
5.00
0
5.00
0%
Operating Profit (PBDIT)
36.00
0
36.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
36.00
0
36.00
0%
Depreciation
3.00
0
3.00
0%
Profit Before Taxation & Exceptional Items
32.00
0
32.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
32.00
0
32.00
0%
Provision for Tax
12.00
0
12.00
0%
Profit After Tax
20.00
0
20.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
41.00
0
41.00
0%
Profit Available for appropriations
61.00
0
61.00
0%
Appropriations
61.00
0
61.00
0%
Equity Dividend (%)
192.5%
0%
192.50
Earnings Per Share
14.08
0
14.08
0%
Profit And Loss - Net Sales
Net Sales 451.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.33% vs 16.54% in Mar 2024

Profit And Loss - Interest
Interest 0.33 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 29.97% vs 12.71% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 50.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024